Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH

Yudkin, 1999, C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?, Arterioscler Thromb Vasc Biol, 19, 10.1161/01.ATV.19.4.972 Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo, J Clin Endocrinol Metab, 82, 4196, 10.1210/jc.82.12.4196 Dandona, 2004, Inflammation: the link between insulin resistance, obesity and diabetes, Trends Immunol, 25, 4, 10.1016/j.it.2003.10.013 Alessi, 2000, Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity, Diabetes, 49, 1374, 10.2337/diabetes.49.8.1374 Lundgren, 1996, Elaboration of type-1 plasminogen activator inhibitor from adipocytes, Circulation, 93, 106, 10.1161/01.CIR.93.1.106 Trayhurn, 2004, Adipokines: inflammation and the pleiotropic role of white adipose tissue, Br J Nutr, 92, 347, 10.1079/BJN20041213 Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 Grimble, 2002, Inflammatory status and insulin resistance, Curr Opin Clin Nutr Metab Care, 5, 551, 10.1097/00075197-200209000-00015 Park, 2001, Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J Biol Chem, 276, 7806, 10.1074/jbc.M008922200 Fleming, 2001, Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease, Proc Natl Acad Sci U S A, 98, 8160, 10.1073/pnas.161296298 Knutson, 2005, Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin, Proc Natl Acad Sci U S A, 102, 1324, 10.1073/pnas.0409409102 Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742 Yeh, 2004, Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat, Am J Physiol Gastrointest Liver Physiol, 286, G385, 10.1152/ajpgi.00246.2003 Laftah, 2004, Effect of hepcidin on intestinal iron absorption in mice, Blood, 103, 3940, 10.1182/blood-2003-03-0953 Yamaji, 2004, Inhibition of iron transport across human intestinal epithelial cells by hepcidin, Blood, 104, 2178, 10.1182/blood-2004-03-0829 Pigeon, 2001, A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload, J Biol Chem, 276, 7811, 10.1074/jbc.M008923200 Nicolas, 2002, The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation, J Clin Invest, 110, 1037, 10.1172/JCI0215686 Nemeth, 2003, Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein, Blood, 101, 2461, 10.1182/blood-2002-10-3235 Lee, 2004, The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and β 2-microglobulin-deficient hepatocytes, Proc Natl Acad Sci U S A, 101, 9263, 10.1073/pnas.0403108101 Nemeth, 2004, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J Clin Invest, 113, 1271, 10.1172/JCI200420945 Roy, 2004, An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice, Nat Genet, 36, 481, 10.1038/ng1350 Nieken, 1995, Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients, Blood, 86, 900, 10.1182/blood.V86.3.900.900 Means, 2004, Hepcidin and anaemia, Blood Rev, 18, 219, 10.1016/S0268-960X(03)00066-3 Brunt, 2000, Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond, Hepatology, 31, 241, 10.1002/hep.510310136 Scheuer, 1994 Anty, 2006, The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH, Am J Gastroenterol, 10.1111/j.1572-0241.2006.00724.x Gabrielsson, 2005, Evaluation of reference genes for studies of gene expression in human adipose tissue, Obes Res, 13, 649, 10.1038/oby.2005.72 Schmid-Alliana, 1998, Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells, J Biol Chem, 273, 3394, 10.1074/jbc.273.6.3394 Kallen, 2002, The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases, Biochim Biophys Acta, 1592, 323, 10.1016/S0167-4889(02)00325-7 Schobitz, 1995, Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo, FASEB J, 9, 659, 10.1096/fasebj.9.8.7768358 Liu, 2005, Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages, Blood Cells Mol Dis, 35, 47, 10.1016/j.bcmd.2005.04.006 Clement, 2004, Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects, FASEB J, 18, 1657, 10.1096/fj.04-2204com Frazer, 2004, Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE, Br J Haematol, 126, 434, 10.1111/j.1365-2141.2004.05044.x Lee, 2005, Regulation of hepcidin transcription by interleukin-1 and interleukin-6, Proc Natl Acad Sci U S A, 102, 1906, 10.1073/pnas.0409808102 Aldhahi, 2003, Adipokines, inflammation, and the endothelium in diabetes, Curr Diabetes Rep, 3, 293, 10.1007/s11892-003-0020-2 Rivera, 2005, Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs, Blood, 106, 2196, 10.1182/blood-2005-04-1766 Frazer, 2003, The orchestration of body iron intake: how and where do enterocytes receive their cues?, Blood Cells Mol Dis, 30, 288, 10.1016/S1079-9796(03)00039-1 Bugianesi, 2004, Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver, Hepatology, 39, 179, 10.1002/hep.20023 Wenzel, 1962, Hypoferraemia in obese adolescents, Lancet, 2, 327, 10.1016/S0140-6736(62)90110-1 Seltzer, 1963, Serum iron and iron-binding capacity in adolescents, Am J Clin Nutr, 13, 343, 10.1093/ajcn/13.6.343 Pinhas-Hamiel, 2003, Greater prevalence of iron deficiency in overweight and obese children and adolescents, Int J Obes Relat Metab Disord, 27, 416, 10.1038/sj.ijo.0802224 Nead, 2004, Overweight children and adolescents: a risk group for iron deficiency, Pediatrics, 114, 104, 10.1542/peds.114.1.104